US-20260124387-A1 - INTELLIGENT INJECTION DEVICE SYSTEMS AND METHODS FOR ADMINISTRATION AND MANAGEMENT OF NUTRICEUTICALS

US20260124387A1US 20260124387 A1US20260124387 A1US 20260124387A1US-20260124387-A1

Abstract

A device may receive patient-specified supplement regimen data through the supplement regimen compliance platform. A device may validate a proposed supplement administration against the patient-specified supplement regimen stored in the supplement regimen compliance platform. A device may constrain intelligent injection device operation through the microprocessor to permit supplement administration only upon successful validation of conformance with the patient-specified supplement regimen. A device may administer a plurality of supplement types simultaneously through the intelligent injection device, wherein the simultaneous injection includes delivering multiple nutraceuticals, vitamins, or health supplements in predetermined ratios that conform to the patient-specified supplement regimen. A device may unlock the switch of the intelligent injection device during authorized supplement administration. A device may automatically transmit, via the wireless module, administration data from the intelligent injection device to the supplement regimen compliance platform in response to triggering the switch.

Inventors

Jeremy Corbett

Assignees

DATADOSE, LLC

Dates

Publication Date: 20260507
Application Date: 20251029

Claims (20)

1 . A method for patient-specific supplement regimen administration comprising: providing an intelligent injection device comprising a barrel in fluid communication with a needle, a piston positioned within the barrel, and a microprocessor in electronic communication with a wireless module and a switch; establishing communication between the intelligent injection device and a supplement regimen compliance platform configured to enforce a patient-specified supplement regimen; receiving patient-specified supplement regimen data through the supplement regimen compliance platform; validating a proposed supplement administration against the patient-specified supplement regimen stored in the supplement regimen compliance platform, constraining intelligent injection device operation through the microprocessor to permit supplement administration only upon successful validation of conformance with the patient-specified supplement regimen; administering a plurality of supplement types simultaneously through the intelligent injection device, wherein the simultaneous injection includes delivering multiple nutraceuticals, vitamins, or health supplements in predetermined ratios that conform to the patient-specified supplement regimen; unlocking the switch of the intelligent injection device during authorized supplement administration; automatically transmitting, via the wireless module, administration data from the intelligent injection device to the supplement regimen compliance platform in response to triggering the switch; and recording the administration data in a patient supplement record system configured to maintain compliance documentation for personalized health supplement management.
2 . The method of claim 1 , wherein the intelligent injection device further comprises a temperature sensor in electronic communication with the microprocessor, and wherein constraining intelligent injection device operation includes preventing supplement administration when the temperature sensor detects that supplement temperature is outside predetermined safe range.
3 . The method of claim 1 , wherein the intelligent injection device further comprises a load sensor in electronic communication with the microprocessor for detecting force measurement upon injectable supplement fluid during administration, and wherein the administration data transmitted to the supplement regimen compliance platform includes force measurement data for verifying proper delivery of multiple nutraceuticals in predetermined ratios.
4 . The method of claim 1 , wherein the intelligent injection device further comprises a damage detection system in electronic communication with the microprocessor for detecting device damage, and wherein the supplement regimen compliance platform is configured to prevent unlocking of the intelligent injection device when damage is detected.
5 . The method of claim 4 , wherein the damage detection generates an automatic alert regarding a device integrity issue that could compromise supplement delivery accuracy.
6 . The method of claim 1 , wherein validating the proposed supplement administration includes performing patient verification using at least one of username verification, password verification, patient ID verification, face verification, retinal verification, vocal verification, fingerprint verification, or digital certificate verification.
7 . The method of claim 1 , wherein a compliance score is calculated based on adherence to a patient-specified supplement regimen protocol or personalized health supplement management standard.
8 . The method of claim 1 , further comprising integrating with a wearable device, wherein the supplement regimen compliance platform incorporates at least one of a real-time biomarker measurement, metabolic indicator, or nutritional status datum from the wearable device to dynamically adjust a patient-specified supplement regimen parameter.
9 . The method of claim 1 , wherein the intelligent injection device comprises multiple preloaded chambers containing different nutraceutical compounds that can be combined in customized ratios to create patient-specific supplement formulations based on real-time physiological feedback, wherein the supplement regimen compliance platform calculates optimal supplement combinations for individual patients based on metabolic profiles, nutritional deficiencies, and personalized health supplement management objectives.
10 . The method of claim 1 , wherein the supplement regimen compliance platform includes digital twin capabilities that digitally represent at least one of a patient physical characteristic, metabolic profile, nutritional requirement, or supplement interaction effect, and wherein the patient supplement record system utilizes a digital twin simulation to generate a personalized supplement regimen recommendation.
11 . The method of claim 10 , wherein the personalized supplement regimen recommendation includes at least one of an optimal administration timing, a supplement combination ratio, or a therapeutic outcome prediction tailored to an individual patient digital twin parameter for enhanced personalized health supplement management.
12 . The method of claim 1 , wherein the patient-specified supplement regimen includes at least one of a nutraceutical dosage requirement, a vitamin administration schedule, or a health supplement combination protocol.
13 . The method of claim 1 , wherein the patient-specified supplement regimen data includes at least one of a supplement type identification, a dosage specification for an individual nutraceutical, an administration timing requirement, or a supplement combination permission.
14 . The method of claim 1 , wherein validating the proposed supplement administration includes at least one of a verification of supplement type appropriateness, a verification of a dosage compliance with patient-defined therapeutic range, or an authorization for specific nutraceutical combination.
15 . The method of claim 1 , wherein the administration data includes at least one of a supplement type identification, a dosage amount for a supplement, or a regimen compliance verification.
16 . A nutraceutical administration system with patient-specific regimen enforcement comprising: an intelligent injection device comprising: a barrel in fluid communication with a needle connected with a first end of the barrel, a piston comprising a plunger positioned within a second end of the barrel with fluid-tight interaction with an interior of the barrel, multiple chambers configured to contain different nutraceutical compounds, vitamins, or health supplements, valve control mechanisms configured to selectively combine contents from multiple chambers in predetermined ratios for simultaneous delivery of a plurality of supplement types, a microprocessor in electronic communication with a switch and a wireless module, the microprocessor configured to send administration data from the wireless module after triggering the switch; a patient supplement regimen system configured to: store patient-specified supplement regimens; validate supplement administration requests against patient-specified regimen parameters and therapeutic objectives, constrain intelligent injection device operation to permit supplement administration only when proposed combinations conform to patient-defined supplement guidelines and nutritional goals; a supplement record system configured to: receive and store administration data from the intelligent injection device with supplement type categorization and dosage verification for individual nutraceuticals administered simultaneously, maintain patient supplement compliance documentation demonstrating adherence to patient-specified regimens and personalized health objectives, generate supplement administration reports for patient review and healthcare provider consultation, provide patients with access to supplement administration histories and regimen compliance verification records; wherein the patient supplement regimen system is configured to enforce real-time compliance with patient-specified supplement regimens by preventing unauthorized nutraceutical administration and ensuring that all supplement combinations conform to patient-defined therapeutic guidelines and personalized nutritional objectives while enabling simultaneous delivery of multiple approved supplement types through coordinated multi-chamber operation.
17 . The nutraceutical administration system of claim 16 , wherein the patient-specified supplement regimens include at least one of a personalized nutraceutical dosage requirement, a vitamin administration protocol, or a health supplement combination restriction defined by an individual patient.
18 . The nutraceutical administration system of claim 16 , wherein the intelligent injection device further comprises a temperature sensor in electronic communication with the microprocessor, and wherein the patient supplement regimen system is configured to enforce a temperature-specific storage requirement for a plurality of nutraceutical formulations by preventing supplement administration when the temperature sensor detects that supplement temperature is outside a predetermined safe range.
19 . The nutraceutical administration system of claim 16 , wherein the intelligent injection device further comprises a damage detection system in electronic communication with the microprocessor for detecting device damage, and wherein the patient supplement regimen system is configured to prevent unlocking of the intelligent injection device when damage is detected.
20 . The nutraceutical administration system of claim 19 , wherein damage detection automatically generates an alert regarding a device integrity issue that could compromise supplement delivery accuracy.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a continuation of International Application No. PCT/US2025/053140, filed on Oct. 29, 2025, which is a continuation of U.S. patent application Ser. No. 19/373,017, filed on Oct. 29, 2025, which is a continuation-in-part of U.S. patent application Ser. No. 19/314,854, filed on Aug. 29, 2025, which is a continuation-in-part of U.S. patent application Ser. No. 19/281,005, filed on Jul. 25, 2025, which is a continuation of U.S. patent application Ser. No. 19/031,862, filed on Jan. 18, 2025, which is a continuation of U.S. patent application Ser. No. 19/030,829, filed on Jan. 17, 2025, which claims the benefit of U.S. provisional application no. 63/715,505, filed on Nov. 1, 2024, which are all hereby incorporated by reference in their entirety. FIELD The present disclosure relates generally to a management platform for injection devices, such as syringes, and, more particularly, to data reporting regarding administration completion of an injectable pharmaceutical. BACKGROUND Understanding administration of drugs and their interaction in the healthcare ecosystem are important in delivering beneficial patient care. Applicant appreciates that regular pharmaceutical therapy and a need for real time data management related to both timing of and compliance in dosing bundled with increased information sharing across the care continuum can provide valuable insight for improving care and, in turn, reducing fraud, waste, and abuse. SUMMARY In some aspects, the techniques described herein relate to a method for patient-specific supplement regimen administration including: providing an intelligent injection device including a barrel in fluid communication with a needle, a piston positioned within the barrel, and a microprocessor in electronic communication with a wireless module and a switch; establishing communication between the intelligent injection device and a supplement regimen compliance platform configured to enforce a patient-specified supplement regimen; receiving patient-specified supplement regimen data through the supplement regimen compliance platform; validating a proposed supplement administration against the patient-specified supplement regimen stored in the supplement regimen compliance platform, constraining intelligent injection device operation through the microprocessor to permit supplement administration only upon successful validation of conformance with the patient-specified supplement regimen; administering a plurality of supplement types simultaneously through the intelligent injection device, wherein the simultaneous injection includes delivering multiple nutraceuticals, vitamins, or health supplements in predetermined ratios that conform to the patient-specified supplement regimen; unlocking the switch of the intelligent injection device during authorized supplement administration; automatically transmitting, via the wireless module, administration data from the intelligent injection device to the supplement regimen compliance platform in response to triggering the switch; and recording the administration data in a patient supplement record system configured to maintain compliance documentation for personalized health supplement management. In some aspects, the techniques described herein relate to a method, wherein the intelligent injection device further includes a temperature sensor in electronic communication with the microprocessor, and wherein constraining intelligent injection device operation includes preventing supplement administration when the temperature sensor detects that supplement temperature is outside predetermined safe range. In some aspects, the techniques described herein relate to a method, wherein the intelligent injection device further includes a load sensor in electronic communication with the microprocessor for detecting force measurement upon injectable supplement fluid during administration, and wherein the administration data transmitted to the supplement regimen compliance platform includes force measurement data for verifying proper delivery of multiple nutraceuticals in predetermined ratios. In some aspects, the techniques described herein relate to a method, wherein the intelligent injection device further includes a damage detection system in electronic communication with the microprocessor for detecting device damage, and wherein the supplement regimen compliance platform is configured to prevent unlocking of the intelligent injection device when damage is detected. In some aspects, the techniques described herein relate to a method, wherein the damage detection generates an automatic alert regarding a device integrity issue that could compromise supplement delivery accuracy. In some aspects, the techniques described herein relate to a method, wherein validating the proposed supplement administration includes performing patient verification using at least one of username verification, password verifica